The Science of Diabetic Snack Bars: A Review

Rafkin-Mervis, Lisa E. MS, RD, CDE
Marks, Jennifer B. MD, CDE

Lisa E. Rafkin-Mervis, MS, RD, CDE, is co-director of the Operations Coordinating Center for the Diabetes Prevention Trial-Type 1 (DPT-1) at the University of Miami School of Medicine in Miami, Fla. Jennifer B. Marks, MD, CDE, is an associate professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at the University of Miami School of Medicine and section chief of Endocrinology, Diabetes, and Metabolism at the Miami VA Medical Center.

Note of Disclosure: Ms. Rafkin-Mervis has served as a consultant to Clinical Products, Ltd., makers of Extend Bar.

Clinical Diabetes 19(1):p 4-12, Winter 2001.

IN BRIEF

Diabetic snack bars are formulated to either prevent hypoglycemia or reduce postprandial hyperglycemia. This article reviews this new product category and the evidence-based claims associated with specific products. Diabetes health care providers and their patients should be aware of how products differ based on ingredient formulations and intended uses.